Question 1

Am I eligible for this trial based on my current health conditions?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus clinical trial (NCT01370005). Contact the study team or your healthcare provider for specific answers.

Question 2

How does BI 10773 compare to my current diabetes and blood pressure medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus clinical trial (NCT01370005). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of BI 10773?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus clinical trial (NCT01370005). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus clinical trial (NCT01370005). Contact the study team or your healthcare provider for specific answers.

Question 5

What tests or monitoring would I undergo while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus clinical trial (NCT01370005). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus clinical trial (NCT01370005). Contact the study team or your healthcare provider for specific answers.

What this study is about